At the Helen Foundation, we understand how detrimental multiple sclerosis (MS) can be when going through daily life and have created a solution to reduce its inflammation issues.
Through hydrocortisone microdosing, we have found a safe and effective way to reduce inflammation issues of MS, by having patients only taking the microdose on bad days of their inflammation and not on the good ones.
When hydrocortisone is used this way in small microdoses, it has been shown to be extremely effective at reducing the inflammation of MS.
Our studies have shown that those battling moderate to severe MS, have seen 67% average symptom improvement through MICRODOSE THERAPY TM, with the therapy beginning its work in as little as one week with maximum disease control at six weeks. By comparison, Copaxone averages 16% symptom improvement for MS treatment.
Hydrocortisone is produced naturally in the body to reduce inflammation, but this production can dip as we age. When administered properly, a hydrocortisone microdose will increase hydrocortisone up to the required levels for the body to arrest inflammation with no side effects. This method is so effective in fact, that medical doctors use it on themselves to reduce inflammation in their own bodies.
If you feel that microdose therapy for multiple sclerosis is right for you and you would like to learn more, we are standing by to help you gain a better understanding of these microdosing techniques.
As you begin your microdosing journey our team will measure your MS’ severity daily, offer prescriptions from doctors by telemedicine and provide an easy-to-understand Patient Education Manual.